Evaluation of dendritic cell population in chronic obstructive pulmonary disease
César Gutiérrez(Wake Forest University), José Luís López-Campos(Instituto de Salud Carlos III), Daniela Tobar(Hospital Universitario Virgen del Rocío), Ana Montes(Guy's and St Thomas' NHS Foundation Trust), Nicolas Moreno(Hospital Universitario Virgen del Rocío), Carmen Calero(Hospital Universitario Virgen del Rocío), Elena Arellano(Instituto de Biomedicina de Sevilla), Ana Blanco(Hospital Universitario Virgen del Rocío)
European Respiratory Journal
September 1, 2012
Cited by 0
Related Papers
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
|The Lancet Oncology|2021|614
Self-medication with Antimicrobial Drugs in Europe
|Emerging infectious diseases|2006|595
An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor
|Gynecologic Oncology|2019|104
Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes
|British Journal of Cancer|2022|89